Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

被引:78
作者
Anczukow, Olga [1 ,2 ]
Ware, Mark D. [1 ,2 ]
Buisson, Monique [1 ,2 ]
Zetoune, Almoutassem B. [1 ,2 ]
Stoppa-Lyonnet, Dominique [3 ]
Sinilnikova, Olga A. [1 ,2 ,4 ]
Mazoyer, Sylvie [1 ,2 ]
机构
[1] CNRS, Fac Med, Lab Genet Mol Signalisat & Canc, UMR5201, F-69373 Lyon 08, France
[2] Univ Lyon 1, F-69365 Lyon, France
[3] Inst Curie, Serv Genet Oncol, Paris, France
[4] Hosp Civils Lyon Ctr, Unite Mixte Genet Constitut Canc Frequents, Lyon, France
关键词
BRCA1; CHK2; p53; nonsense-mediated mRNA decay; truncated protein; breast cancer predisposition;
D O I
10.1002/humu.20590
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The nonsense-mediated mRNA decay (NMD) mechanism is an evolutionarily conserved process ensuring the degradation of transcripts carrying premature termination codon(s). NMD is believed to prevent the synthesis of truncated proteins that could be detrimental to the cell. However, although numerous studies have assessed the efficiency of this mechanism at the mRNA level, data are lacking in regard to whether NMD fulfills its expected goal at the protein level. In this study, we have investigated whether endogenous alleles of breast cancer predisposing genes carrying nonsense codons were able to produce detectable amounts of truncated proteins in lymphoblastoid cell lines. A total of 20 truncating BRCA1 mutations were analyzed, along with the 1100delC CHEK2 and the 770delT TP53 mutations. All the studied alleles triggered NMD, the amount of mutant transcript ranging from 16 to 63% of that of the wild,type species. We found that BRCA1 and CHK2 truncated proteins could not be detected, even when NMD was inhibited. This suggests that BRCA1 and CHK2 truncated proteins are highly unstable. Conversely, the p53 protein encoded by the 770delT allele is as abundant as the wild,type protein, as removal of the C,terminal p53 domain leads to a stabilized mutant protein, whose abundance is markedly increased when NMD is inhibited. Therefore, our results show that it is not possible to infer the presence of truncated proteins in cells from carriers of a truncated mutation without experimental verification, as each case is expected to be different.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 32 条
[1]   Regulation of BRCA1 by protein degradation [J].
Blagosklonny, MV ;
An, WG ;
Melillo, G ;
Nguyen, P ;
Trepel, JB ;
Neckers, LM .
ONCOGENE, 1999, 18 (47) :6460-6468
[2]   p53 isoforms can regulate p53 transcriptional activity [J].
Bourdon, JC ;
Fernandes, K ;
Murray-Zmijewski, F ;
Liu, G ;
Diot, A ;
Xirodimas, DP ;
Saville, MK ;
Lane, DP .
GENES & DEVELOPMENT, 2005, 19 (18) :2122-2137
[3]   Expression of mutant JAGGED1 alleles in patients with Alagille syndrome [J].
Boyer, J ;
Crosnier, C ;
Driancourt, C ;
Raynaud, N ;
Gonzales, M ;
Hadchouel, M ;
Meunier-Rotival, M .
HUMAN GENETICS, 2005, 116 (06) :445-453
[4]   The 185delAG mutation (c.68_ 69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon [J].
Buisson, Monique ;
Anczukow, Olga ;
Zetoune, Almoutassem B. ;
Ware, Mark D. ;
Mazoyer, Sylvie .
HUMAN MUTATION, 2006, 27 (10) :1024-1029
[5]   Ubiquitination and proteasomal degradation the BRCA1 tumor suppressor is regulated during cell cycle progression [J].
Choudhury, AD ;
XuO, H ;
Baer, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33909-33918
[6]   Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species [J].
Conti, E ;
Izaurralde, E .
CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (03) :316-325
[7]  
Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251
[8]  
Flaman JM, 1996, ONCOGENE, V12, P813
[9]   The position of premature termination codons in the hepatocyte nuclear factor-1 beta gene determines susceptibility to nonsense-mediated decay [J].
Harries, LW ;
Bingham, C ;
Bellanne-Chantelot, C ;
Hattersley, AT ;
Ellard, S .
HUMAN GENETICS, 2005, 118 (02) :214-224
[10]   Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations [J].
Inoue, K ;
Khajavi, M ;
Ohyama, T ;
Hirabayashi, S ;
Wilson, J ;
Reggin, JD ;
Mancias, P ;
Butler, IJ ;
Wilkinson, MF ;
Wegner, M ;
Lupski, JR .
NATURE GENETICS, 2004, 36 (04) :361-369